Moreover, the NRF2-dependent defense systems support survival of cancer cells during treatment with chemotherapeutic and target therapeutic agents, as many genes and pathways reported to play roles in anticancer drug resistance seemed to have a regulatory and functional link with NRF2. The gene discussed is NFE2L2; the disease is cancer.